Company news
Dawnrays Pharmaceutical Holdings Ltd. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Next Day Disclosure Return
November 2, 2026
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
November 2, 2026
Next Day Disclosure Return
October 30, 2026
Next Day Disclosure Return
October 29, 2026
Next Day Disclosure Return
October 28, 2026
Next Day Disclosure Return
October 27, 2026
Next Day Disclosure Return
October 26, 2026
Next Day Disclosure Return
October 23, 2026
Next Day Disclosure Return
October 22, 2026
Next Day Disclosure Return
October 21, 2026
Next Day Disclosure Return
October 20, 2026
Next Day Disclosure Return
October 16, 2026
Next Day Disclosure Return
October 15, 2026
Next Day Disclosure Return
October 14, 2026
(Revised) Next Day Disclosure Return
October 14, 2026
Next Day Disclosure Return
October 13, 2026
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
October 5, 2026
Notification letter and request form to non-registered holder - notice of publication of 2026 interim report
September 17, 2026
Notification letter and reply form to registered shareholders - notice of publication of 2026 interim report
September 17, 2026
2026 Interim report
September 17, 2026
Discloseable transaction - investment in a limited partnership
June 18, 2026
Dawnrays Pharmaceutical Holdings: Proposals for general mandates to issue and repurchase shares; re-election of directors and notice of annual general meeting
April 19, 2021
Next Day Disclosure Return
September 23, 2020
Dawnrays Pharmaceutical Holdings: Supplemental announcement in relation to 2019 annual report
August 20, 2020
Discloseable transaction-construction agreements
August 14, 2020
Announcement of Interim Results for the six months ended 30 June 2017
August 22, 2017
Change in board lot size
August 4, 2017
List of Directors and their Role and Function
March 30, 2012
Dawnrays Pharmaceutical (Holdings) Limited Announced Annual Results for the Year Ended 31 December 2011, Net Profit after Tax Dropped 12.3% to RMB 146.31 Million, A Final Dividend of HK$ 0.068 per Share was Declared
March 23, 2012
Date of Board Meeting
March 5, 2012
Voluntary Announcement New Product Pharmaceutical Registration Approval
December 20, 2011
Dawnrays Pharmaceutical (Holdings) Limited Announced Interim Results for the Six Months Ended 30 June 2011: Net Profit after Tax Jumped 2.9% to RMB 90.06 Million, an Interim Dividend of HK$ 0.02 per Share was Declared
August 23, 2011